Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Post by doubleLson Aug 14, 2019 9:43am

199 Views

Post# 30026559

Our revenue and revenue growth beats tilray

Our MCAP is $750mm??? Come on now folks. Might take one of these monster LPs trying to buy us out to get our proper value realized ahead of Canadian edibles. The market should be rewarding us un comparative value today!!!

Bullboard Posts

Visionstate set to leverage success in the U.S. market